CD4 cell counts at the third month of HAART may predict clinical failure-Reference-Cited by-同舟云学术

CD4 cell counts at the third month of HAART may predict clinical failure

Published:1999-09 Issue:13 Volume:13 Page:1669-1676
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Monforte Antonella d‚Arminio,Testori Valeria,Adorni Fulvio,Castelnuovo Barbara,Bini Teresa,Testa Letizia,Moscatelli GianCarla,Chiesa Elisabetta,Rusconi Stefano,Abeli Clara,Sollima Salvatore,Musicco Massimo,Meroni Luca,Galli Massimo,Moroni Mauro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference15 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres

3. Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease

4. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy

5. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studies on the prevalence of HIV/AIDS in Bangladesh including other developing countries;Advances in Traditional Medicine;2021-09-20

2. Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial;PLoS ONE;2013-11-14

3. Immune interventions in HIV infection;Immunological Reviews;2013-06-16

4. Impaired CD4+ T-Cell Restoration in the Small Versus Large Intestine of HIV-1–Positive South Africans Receiving Combination Antiretroviral Therapy;The Journal of Infectious Diseases;2013-06-06

5. Beneficial Effects of a Switch to a Lopinavir/ritonavir-Containing Regimen for Patients with Partial or No Immune Reconstitution with Highly Active Antiretroviral Therapy Despite Complete Viral Suppression;AIDS Research and Human Retroviruses;2011-06